SWITCH THERAPEUTICS

In News

Leading with resilience: Dee Datta’s journey from Caltech Labs to biotech entrepreneurship - The Business Journals

The Business Journals - Sep 09, 2025

Dual switches ignite tumour-specific mRNA therapeutics - Nature

Nature - Nov 12, 2025

Atalanta banks $97M to send RNAi drugs into the brain - BioPharma Dive

BioPharma Dive - Jan 28, 2025

Predictors of therapy switching to high-efficacy disease-modifying therapies in patients with multiple sclerosis: a single center, retrospective, observational study - Frontiers

Frontiers - Oct 08, 2025

Integrating ON-OFF switches for targeted mRNA therapeutics - Phys.org

Phys.org - Jul 07, 2025

JPM 2025: $1B women's health and RNAi innovations featured - drugdiscoverytrends.com

drugdiscoverytrends.com - Jan 21, 2025

Another Bay Area biotech company announces layoffs - KRON4

KRON4 - May 06, 2025

Acrivon stops developing Lilly castoff for ovarian and bladder cancers to switch focus to endometrial - Fierce Biotech

Fierce Biotech - Mar 26, 2025

Switch Therapeutics Appoints David M. Holtzman, M.D., to Its Scientific Advisory Board and Announces Its First Development Candidate, CASi-APOE, a Liver-Sparing APOE RNAi Therapy - BioSpace

BioSpace - Dec 03, 2024

Switch Therapeutics Launches to Develop Targeted siRNA Therapies - Inside Precision Medicine

Inside Precision Medicine - Mar 14, 2023

Switch Therapeutics nominates liver-sparing APOE RNAi therapy as development candidate for Alzheimer’s - BioWorld MedTech

BioWorld MedTech - Dec 04, 2024

Editor’s pick: Switch Therapeutics - Nature

Nature - Oct 14, 2024

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment